When we inhibited CDC7 in liver cancer cells with the CDC7 inhibitor XL413, we observed strong suppression of its downstream target p-MCM2 at XL413 concentrations of 5 μM to 10 μM (Fig. 3G). Here, MCM2 is linked to liver cancer.